Exact Mass: 401.1559934

Exact Mass Matches: 401.1559934

Found 362 metabolites which its exact mass value is equals to given mass value 401.1559934, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Moxifloxacin

7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C21H24FN3O4 (401.1750756)

Moxifloxacin is only found in individuals that have used or taken this drug. It is a synthetic fluoroquinolone antibiotic agent. Bayer AG developed the drug (initially called BAY 12-8039) and it is marketed worldwide (as the hydrochloride) under the brand name Avelox (in some countries also Avalox) for oral treatment.The bactericidal action of moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

N-[4-[1-[2-(6-Methylpyridin-2-yl)ethyl]piperidine-4-carbonyl]phenyl]methanesulfonamide

N-[4-[1-[2-(6-Methylpyridin-2-yl)ethyl]piperidine-4-carbonyl]phenyl]methanesulphonamide

C21H27N3O3S (401.1773032000001)

D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

Acalisib

C21H16FN7O (401.1400298)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

Margrapine A

4-[(3,3-dimethyloxiran-2-yl)(hydroxy)methyl]-1,6-dihydroxy-3,5-dimethoxy-10-methyl-9,10-dihydroacridin-9-one

C21H23NO7 (401.1474448)

Margrapine A is found in citrus. Margrapine A is an alkaloid from roots of Marsh grapefruit (Citrus paradisi

2-(1-carboxy-2-hydroxypropyl)-4-{[5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2h-pyrrole-5-carboxylic acid

2-(1-Carboxy-2-hydroxypropyl)-4-{[5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulphanyl}-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid

C17H27N3O6S (401.1620482)

artemisone

4-{1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-yl}-1lambda6-thiomorpholine-1,1-dione

C19H31NO6S (401.18719860000004)

Dda-tetracycline

1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-3,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboxamide

C20H19NO8 (401.11106140000004)

3-Quinolinecarboxylic acid, 7-((3R)-3-(1-aminocyclopropyl)-1-pyrrolidinyl)-1-((1R,2S)-2-fluorocyclopropyl)-1,4-dihydro-8-methoxy-4-oxo-

C21H24FN3O4 (401.1750756)

Emapunil

N-Benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide

C23H23N5O2 (401.1851658)

C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

Evogliptin

4-[3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one

C19H26F3N3O3 (401.1926162)

Ghrelin agonist HM01

3-[1-(2,3-dichloro-4-methoxyphenyl)ethyl]-1-methyl-1-(1,3,3-trimethylpiperidin-4-yl)urea

C19H29Cl2N3O2 (401.1636714)

Ipsapirone

2-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-2,3-dihydro-1λ⁶,2-benzothiazole-1,1,3-trione

C19H23N5O3S (401.15215280000007)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Ipsapirone (TVX Q 7821) is an anxiolytic compound and a 5-HT1A receptor partial agonist. Ipsapirone (TVX Q 7821) also exhibits 5-HT1A receptor antagonistic effect, and only at high doses it can also produce an inhibitory effect on 5-HT2 and the α1-adrenergic function[1][2].

Rilmakalim

1-[6-(Benzenesulphonyl)-3-hydroxy-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl]pyrrolidin-2-one

C21H23NO5S (401.12968680000006)

1,4-Bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone

1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)azetidin-2-one

C26H27NO3 (401.1990832)

Setoperone

6-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-7-methyl-2H,3H,5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one

C21H24FN3O2S (401.1573176)

Voreloxin

7-[3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

C18H19N5O4S (401.11576940000003)

Zabofloxacin

1-cyclopropyl-6-fluoro-7-[8-(methoxyimino)-2,6-diazaspiro[3.4]octan-6-yl]-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

C19H20FN5O4 (401.14992520000004)

N-(4-Nitroanilino)-N-(2,2,4,4-tetramethyl-3H-thiochromen-6-yl)methanethioamide

N-[(4-nitrophenyl)amino]-N-(2,2,4,4-tetramethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)carbothioamide

C20H23N3O2S2 (401.1231618)

Risdiplam

7-{4,7-diazaspiro[2.5]octan-7-yl}-2-{2,8-dimethylimidazo[1,2-b]pyridazin-6-yl}-4H-pyrido[1,2-a]pyrimidin-4-one

C22H23N7O (401.1963988)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System M - Musculo-skeletal system

Dehydrocorydaline

C22H24NO4+.Cl- (401.13937740000006)

Papaverrubine G

C22H27NO6 (401.18382820000005)

Acetylleucovernine

C22H27NO6 (401.18382820000005)

Alpinigenin

C22H27NO6 (401.18382820000005)

(+)-trans-Erioaustralasine hydrate

C22H27NO6 (401.18382820000005)

Isonoyaine

C21H23NO7 (401.1474448)

31F508a2

Bioxalomycin alpha2

C21H27N3O5 (401.19506120000005)

N-Acetylisopenicillin N

C16H23N3O7S (401.12566480000004)

Tirandamycin D

C22H27NO6 (401.18382820000005)

Ceratocapnidine

C21H23NO7 (401.1474448)

Lucilactaene

C22H27NO6 (401.18382820000005)

Clivacetine

C21H23NO7 (401.1474448)

Noyaine

C21H23NO7 (401.1474448)

(3S)-Stemofolenol

C22H27NO6 (401.18382820000005)

1,2-Didehydrostemofoline N-oxide

C22H27NO6 (401.18382820000005)

SCHEMBL7954420

C19H28ClNO6 (401.16050580000007)

SAR115740

C24H17F2N3O (401.1339616)

CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5063; ORIGINAL_PRECURSOR_SCAN_NO 5061 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5071; ORIGINAL_PRECURSOR_SCAN_NO 5068 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5038; ORIGINAL_PRECURSOR_SCAN_NO 5036 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5069; ORIGINAL_PRECURSOR_SCAN_NO 5067 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5072; ORIGINAL_PRECURSOR_SCAN_NO 5070 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5063; ORIGINAL_PRECURSOR_SCAN_NO 5059 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9533; ORIGINAL_PRECURSOR_SCAN_NO 9531 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9575; ORIGINAL_PRECURSOR_SCAN_NO 9573 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9589; ORIGINAL_PRECURSOR_SCAN_NO 9587 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9621; ORIGINAL_PRECURSOR_SCAN_NO 9618 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9628; ORIGINAL_PRECURSOR_SCAN_NO 9625 CONFIDENCE standard compound; INTERNAL_ID 509; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9642; ORIGINAL_PRECURSOR_SCAN_NO 9639

JWH-369

C26H24ClNO (401.1546324)

MLS000860639

C21H27N3O3S (401.1773032000001)

Maybridge4_003998

C16H18F3N5O2S (401.1133244)

3-(1-(cyclohexylmethyl)-1h-indazole-3-carboxamido)-2,2-dimethylsuccinic acid

C21H27N3O5 (401.19506120000005)

CHEMBL3115821

C23H20FN5O (401.1651802)

UNII-MO0L3R7QL7

C20H23N3O4S (401.14091980000006)

2-demethylcolchifoline

C21H23NO7 (401.1474448)

1-[2-(Hydroxymethyl)-3,4-dimethoxybenzyl]-2-methyl-1,2,3,4-tetrahydro-6,7-(methylenebisoxy)-8-methoxyisoquinoline

C22H27NO6 (401.18382820000005)

Tirandalydigin

C22H27NO6 (401.18382820000005)

3-demethylcolchifoline|colchifoline

C21H23NO7 (401.1474448)

(Iso) Drosopterin

C16H19N9O4 (401.1559934)

SCHEMBL5636517

C15H24N5O6P (401.14641340000003)

Nikkomycin M

C15H19N3O10 (401.10703939999996)

C21H23NO7

C21H23NO7 (401.1474448)

bisdehydrostemoninine A

C22H27NO6 (401.18382820000005)

epi-aszonalenin B

C24H23N3O3 (401.1739328)

Katorazone

C23H19N3O4 (401.13754940000007)

scholarisin IV

C21H27N3O5 (401.19506120000005)

Aurantiamide

C26H27NO3 (401.1990832)

Lamellarin R

C24H19NO5 (401.12631640000006)

ethyl 3-indoleacryltryptophan ester

C24H23N3O3 (401.1739328)

Nikkomycin N

C15H19N3O10 (401.10703939999996)

C21H27N3O5

C21H27N3O5 (401.19506120000005)

7-Hydroxyneolamellarin A

C24H19NO5 (401.12631640000006)

7-butyl-3,4,9-trihydroxy-8-methoxy-5,10-dioxo-5,10-dihydro-benzo[g]quinoline-2-carboxylic acid methyl ester

C20H19NO8 (401.11106140000004)

NEOLAMELLARIN B

C24H19NO5 (401.12631640000006)

alpha,beta-Dihydro-beta-lumicolchicin|Lumicolchicin I

C22H27NO6 (401.18382820000005)

Xanthiside

8,8-dimethyl-7-[[(2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4H-1,4-benzothiazine-3,5-dione

C17H23NO8S (401.11443180000003)

Tyr Gly Tyr

C20H23N3O6 (401.1586778)

Asp Met His

C15H23N5O6S (401.13689780000004)

Met His Asp

C15H23N5O6S (401.13689780000004)

ACMC-20mh0j

C20H23N3O6 (401.1586778)

His Met Asp

C15H23N5O6S (401.13689780000004)

Met Asp His

C15H23N5O6S (401.13689780000004)

Asp His Met

C15H23N5O6S (401.13689780000004)

Dehydrocorydalinechloride

2,3,9,10-tetramethoxy-13-methyl-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium;chloride

C22H24ClNO4 (401.13937740000006)

Dehydrocorydaline chloride (13-Methylpalmatine chloride) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline chloride elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline chloride shows strong anti-malarial effects (IC50?=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline chloride (13-Methylpalmatine chloride) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline chloride elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline chloride shows strong anti-malarial effects (IC50?=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].

Puerins I-IV

C21H23NO7 (401.1474448)

E-4031

N-[4-[1-[2-(6-Methylpyridin-2-yl)ethyl]piperidine-4-carbonyl]phenyl]methanesulfonamide

C21H27N3O3S (401.1773032000001)

D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Moxifloxacin

1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid

C21H24FN3O4 (401.1750756)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

MMV688372

C23H20N5OF (401.1651802)

trans-erioaustralasine hydrate

C22H27NO6 (401.18382820000005)

MMV688372

C23H20FN5O (401.1651802)

1-Pyridylhydroxybutyl-deoxyinosine

C19H23N5O5 (401.1699108)

Ala Asn Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid